Date: Mar 10, 2015 Source: BioPortfolio (
click here to go to the source)
HealthMyne, Inc., an early stage healthcare informatics company focused on bringing evidence-based imaging analysis to the point of care, announced today that it has raised $4.5m in a Series A round of investment. The round was led by two local Madison-based venture firms -- Venture Investors and 4490 Ventures. Additional participation included HealthX Ventures and several prominent angel investors.
HealthMyne was founded in 2013 by a seasoned group of passionate healthcare industry entrepreneurs who have enjoyed overlapping business success. Their prior start-up experiences include TomoTherapy, Geometrics, and UltraVisual. According to Rock Mackie, a HealthMyne founder, "There's been a lot of attention directed toward personalized health and evidence-based medicine, but we feel confident that we are in the best position to turn that vision into reality for clinical imaging and oncology. Importantly, the first step began with the formation of our truly industry-leading team."
HealthMyne is focused on providing novel search, analytics, and imaging (SAI) solutions to cancer care providers. Its innovative SAI technology provides physicians with enhanced tumor image manipulation, as well as EHR and image repository search capabilities for diagnosing and treating similar cases. The first product, launching later this year, will help clinicians better detect and diagnose lung nodules as part of a comprehensive low dose CT lung screening program.
"In order to move to a whole new level of patient care, healthcare enterprises must find a way to unlock the power, and resulting impact, contained within their big data -- and there is no bigger sea of digital data than that contained in clinical imaging," said Scott Button, Managing Director at Venture Investors.
"Obviously, there is significant investment occurring in healthcare informatics, especially within the data analytics segment," said Greg Robinson, Managing Director at 4490 Ventures. "However, what makes HealthMyne so exciting is their unique position and proven expertise relative to clinical imaging analysis. Although this is a challenging area, it offers tremendous economic and clinical benefit opportunities."
The funds will be used to expand and accelerate HealthMyne's product development, regulatory, and commercialization efforts.
